Allarity Therapeutics, Inc. Adjustments to Additional Paid in Capital, Other
Allarity Therapeutics, Inc. (ALLR) reported Adjustments to Additional Paid in Capital, Other of -$3.42 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-08.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2024-03-08
- Allarity Therapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2022-06-30 was $1.38M.
- Allarity Therapeutics, Inc. adjustments to additional paid in capital, other for the quarter ending 2022-03-31 was $134.00K.
- Allarity Therapeutics, Inc. adjustments to additional paid in capital, other for fiscal 2022 was -$3.42M.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|
| 2022-12-31 | -$3.42M 10-K · filed 2024-03-08 | ||
| 2022-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.51M 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $134.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |